Condor Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,714
| Closed | -$82K | – | 184 |
|
|
2016
Q3 | $82K | Hold |
2,714
| – | – | 0.02% | 182 |
|
|
2016
Q2 | $77K | Hold |
2,714
| – | – | 0.02% | 181 |
|
|
2016
Q1 | $73K | Buy |
+2,714
| New | +$73K | 0.02% | 182 |
|
|
2015
Q4 | – | Sell |
-3,671
| Closed | -$134K | – | 187 |
|
|
2015
Q3 | $134K | Hold |
3,671
| – | – | 0.04% | 179 |
|
|
2015
Q2 | $138K | Hold |
3,671
| – | – | 0.03% | 183 |
|
|
2015
Q1 | $145K | Sell |
3,671
-570
| -13% | -$22.5K | 0.03% | 184 |
|
|
2014
Q4 | $174K | Buy |
4,241
+635
| +18% | +$26.1K | 0.05% | 164 |
|
|
2014
Q3 | $159K | Hold |
3,606
| – | – | 0.04% | 159 |
|
|
2014
Q2 | $156K | Buy |
3,606
+1,256
| +53% | +$54.3K | 0.04% | 160 |
|
|
2014
Q1 | $96K | Buy |
+2,350
| New | +$96K | 0.03% | 161 |
|